Related Experiment Video
Updated: Oct 30, 2025

MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
Inhibition of p38 Mitogen-Activated Protein Kinase Impairs Mayaro Virus Replication in Human Dermal Fibroblasts and
Madelaine Sugasti-Salazar1,2, Yessica Y Llamas-González1,3, Dalkiria Campos1
1Grupo de Biología Celular y Molecular de Arbovirus, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panamá 0816-02593, Panama.
Abstract:
Mayaro virus (MAYV) hijacks the host's cell machinery to effectively replicate. The mitogen-activated protein kinases (MAPKs) p38, JNK, and ERK1/2 have emerged as crucial cellular factors implicated in different stages of the viral cycle. However, whether MAYV uses these MAPKs to competently replicate has not yet been determined. The aim of this study was to evaluate the impact of MAPK inhibition on MAYV replication using primary human dermal fibroblasts (HDFs) and HeLa cells. Viral yields in supernatants from MAYV-infected cells treated or untreated with inhibitors SB203580, SP600125, U0126, or Losmapimod were quantified using plaque assay. Additionally, viral protein expression was analyzed using immunoblot and immunofluorescence. Knockdown of p38⍺/p38β isoforms was performed in HDFs using the PROTACs molecule NR-7h. Our data demonstrated that HDFs are highly susceptible to MAYV infection. SB203580, a p38 inhibitor, reduced MAYV replication in a dose-dependent manner in both HDFs and HeLa cells. Additionally, SB203580 significantly decreased viral E1 protein expression. Similarly, knockdown or inhibition of p38⍺/p38β isoforms with NR-7h or Losmapimod, respectively, affected MAYV replication in a dose-dependent manner. Collectively, these findings suggest that p38 could play an important role in MAYV replication and could serve as a therapeutic target to control MAYV infection.
Insights
Mayaro virus (MAYV) replication is significantly impacted by p38, a key mitogen-activated protein kinase (MAPK). Inhibiting p38 reduces viral load and protein expression, suggesting p38 as a potential therapeutic target for MAYV infection.
Area of Science:
- Virology
- Cellular Biology
- Molecular Medicine
Background:
- Mayaro virus (MAYV) utilizes host cell machinery for replication.
- Mitogen-activated protein kinases (MAPKs), including p38, JNK, and ERK1/2, are implicated in viral cycles.
- The specific role of MAPKs in MAYV replication remains largely undetermined.
Purpose of the Study:
- To investigate the impact of inhibiting specific MAPKs on MAYV replication.
- To determine if MAYV utilizes p38, JNK, or ERK1/2 pathways for efficient replication.
- To evaluate p38 as a potential therapeutic target against MAYV infection.
Main Methods:
- MAYV replication was assessed in primary human dermal fibroblasts (HDFs) and HeLa cells.
- Cells were treated with MAPK inhibitors (SB203580, SP600125, U0126, Losmapimod) or subjected to p38 isoform knockdown using PROTACs (NR-7h).
- Viral yields were quantified by plaque assay, and viral protein expression was analyzed via immunoblot and immunofluorescence.
Main Results:
- HDFs exhibited high susceptibility to MAYV infection.
- The p38 inhibitor SB203580 dose-dependently reduced MAYV replication and E1 protein expression in both cell types.
- Inhibition or knockdown of p38α/p38β isoforms (using Losmapimod or NR-7h) also dose-dependently impaired MAYV replication.
Conclusions:
- The p38 pathway plays a significant role in Mayaro virus replication.
- Targeting p38 MAPK activity presents a promising therapeutic strategy for controlling MAYV infections.
- Further research into p38-MAYV interactions could lead to novel antiviral treatments.
Related Concept Videos
Inhibition of Cdk Activity
MAPK Signaling Cascades

